Sec Form 4 Filing - Young David @ QUESTCOR PHARMACEUTICALS INC - 2014-02-24

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Young David 2. Issuer Name and Ticker or Trading Symbol QUESTCOR PHARMACEUTICALS INC [ QCOR] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Scientific Officer (Last) (First) (Middle) 1300 NORTH KELLOGG DRIVE, SUITE D 3. Date of Earliest Transaction (MM/DD/YY) 02/24/2014 (Street) ANAHEIM, CA92807 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock ( 1 ) 02/24/2014 A 14,000 ( 2 ) A $ 0 125,145 D Common Stock ( 1 ) 02/24/2014 A 14,000 ( 3 ) A $ 0 139,145 D Common Stock ( 1 ) 02/24/2014 D 16,667 ( 4 ) D $ 0 122,478 D Common Stock ( 1 ) 02/24/2014 F 17,127 ( 5 ) D $ 79.46 105,351 D Common Stock 02/24/2014 M 6,000 A $ 4.54 111,351 D Common Stock 02/24/2014 S 6,000 D $ 78.8816 105,351 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative S ecurity 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (right to buy) ( 6 ) $ 4.54 02/24/2014 M 6,000 ( 7 ) 10/29/2019 Common Stock 6,000 $ 0 83,000 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Young David 1300 NORTH KELLOGG DRIVE SUITE D ANAHEIM, CA92807 Chief Scientific Officer Signatures /s/David Young 02/26/2014 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Restricted stock granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan. ( 2 )Represents a restricted stock award that vests in four equal annual installments beginning on 2/24/2015. ( 3 )Represents a restricted stock award that vests subject to the achievement of certain performance-based criteria. ( 4 )Represents the forfeiture of restricted stock granted on 2/24/2013 based on the level of achievement of performance criteria for fiscal year 2013. ( 5 )Represents the surrender of shares to the Company to satisfy the reporting person's aggregate tax withholding obligation upon the vesting of shares of restricted stock granted on 2/24/2013. ( 6 )Non-qualified stock options granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan on 10/30/2009. ( 7 )The option was granted on 10/30/2009 for the right to buy 350,000 shares of common stock of the Issuer. The option provided for monthly vesting over 48 months from the date of grant with a twelve month cliff, whereby no options vested until after the twelfth month from the date of grant.

Remarks: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan (the "Automatic Trading Plan") adopted by the reporting person in the fourth quarter of 2013 and effective 30 days post-adoption. There have been no changes to the Automatic Trading Plan since its adoption, and there have been no sales by the Reporting Person outside of the Automatic Trading Plan since its adoption. The Automatic Trading Plan controls the exact dates and amounts of sales.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.